Comments
Loading...

Pharvaris Stock Price, Quotes and Forecasts

PHVSNASDAQ
Logo brought to you by Benzinga Data
$16.60
-0.12-0.72%
At close: -
$16.60
0.000.00%
After Hours: 4:03 PM EDT
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Pharvaris Stock Price, Quotes and Forecasts | NASDAQ:PHVS | Benzinga

Explore Pharvaris stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PHVS.

Open$16.97
Close$16.60
Volume / Avg.189.85K / 65.06K
Day Range$16.26 - $16.99
52 Wk Range11.51 - 25.50
Market Cap$904.59M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
53
Short Interest
1.45%
Days to Cover10.94
About Pharvaris NV
Sector
Healthcare
Industry
N/A
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral br...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PHVS

FAQ

Q

How do I buy Pharvaris (PHVS) stock?

A

You can purchase shares of Pharvaris (NASDAQ:PHVS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pharvaris (PHVS) competitors?

A

There are no as such competitors for Pharvaris.

Q

What is the forecast, or price target, for Pharvaris (PHVS) stock?

A

Pharvaris has a consensus price target of $34.50.

Q

What is the current price for Pharvaris (PHVS)?

A

The stock price for Pharvaris (NASDAQ: PHVS) is $16.6 last updated May 30, 2025 at 4:03 PM EDT.

Q

Does Pharvaris (PHVS) pay a dividend?

A

There are no upcoming dividends for Pharvaris.

Q

When is Pharvaris (NASDAQ:PHVS) reporting earnings?

A

Pharvaris’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Q

Is Pharvaris (PHVS) going to split?

A

There is no upcoming split for Pharvaris.

Q

What sector and industry does Pharvaris (PHVS) operate in?

A

Pharvaris is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.